As research funds become available, the DDF plans to support outstanding research in areas focused on dysimmune diseases. Initially, the focus would be on uses of IVIG for treatment of Neurological Disorders, Dermatological Diseases, Primary Immune Deficiency, Alzheimer's Disease and Down Syndrome. The research funding will be targeted at special aspects of each disease. Future information will follow.